Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mansi Bhurani, Lorenz Admojo, Carrie Van Der Weyden, Robert Twigger, Ali Bazargan, Hang Quach, Allan Zimet, Luke Coyle, Julian Lindsay, Dejan Radeski, Eliza Hawkes, Glen Kennedy, Ian Irving, Naadir Gutta, Judith Trotman, James Yeung, Lindsay Dunlop, Minh Hua, Pratyush Giri, Sam Yuen, Shyam Panicker, Susan Moreton, Liane Khoo, Ashleigh Scott, David Kipp, Andrew McQuillan, Chris McCormack, Michael Dickinson & Henry Miles Prince. (2021) Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. Leukemia & Lymphoma 62:2, pages 330-336.
Read now
Read now
Helen Ma, Owen A. O’Connor & Enrica Marchi. (2019) New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination. Expert Review of Hematology 12:3, pages 137-146.
Read now
Read now
Yuta Ito, Shinichi Makita & Kensei Tobinai. (2019) Development of new agents for peripheral T-cell lymphoma. Expert Opinion on Biological Therapy 19:3, pages 197-209.
Read now
Read now
Shyam Kumar Gajula, Gattu Sridhar, Kiran Gangarapu, Kalyani Sambaru, Rameshwar Nimma, Shireesha Boyapati, Chandrasekhar Vasam & Satyanarayana Mavurapu. Design and Synthesis of Substituted Anilino 6-(3,4,5-Trimethoxyphenyl)Pteridine Derivatives and Invitro Evaluation as Potential Cytotoxic Agents. Polycyclic Aromatic Compounds 0:0, pages 1-13.
Read now
Read now
Articles from other publishers (12)
Serdar Altınay, Alev Kural, Aykut Özmen, Deniz Tural & Yusuf Tutar. (2023) Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The
Prepared Mind. Anti-Cancer Agents in Medicinal Chemistry 23:3, pages 298-305.
Crossref
Crossref
Greg Hapgood, Maya Latimer, Sze Ting Lee, Bryone Kuss, Stephen Lade, Joshua W. D. Tobin, Duncan Purtill, Belinda A. Campbell, H. Miles Prince, Eliza A. Hawkes, Jake Shortt & Dejan Radeski. (2022) Diagnosis, management and follow up of peripheral T‐cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 52:10, pages 1806-1817.
Crossref
Crossref
Neil B. Panchal & Vipul M. Vaghela. (2022) Pteridine a Colored Heterocycle and its Anticancer Activity: An Overview. Oriental Journal Of Chemistry 38:4, pages 822-839.
Crossref
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism
35
67
.
Helen Ma & Owen A. O'Connor. 2021. The Peripheral T‐Cell Lymphomas. The Peripheral T‐Cell Lymphomas
287
304
.
Rachael A. Clark, Sora Lee, Jingbo Qiao & Dai H. Chung. (2020) Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells. Oncotarget 11:32, pages 3069-3077.
Crossref
Crossref
Tianfeng Gao, Congying Zhang, Xiaowei Shi, Ran Guo, Kai Zhang, Jianmin Gu, Lin Li, Shuolei Li, Qianqian Zheng, Mengyu Cui, Miao Cui, Xingmei Gao, Yi Liu & Lei Wang. (2019) Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents. European Journal of Medicinal Chemistry 178, pages 329-340.
Crossref
Crossref
Koichi Kitazume, Yuri Akagawa, Sachie Wada, Takayuki Suzuki & Akira Fujita. (2019) Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin. Case Reports in Oncology 12:2, pages 529-536.
Crossref
Crossref
Violeta Carmona‐Martínez, Antonio J. Ruiz‐Alcaraz, María Vera, Antonio Guirado, María Martínez‐Esparza & Pilar García‐Peñarrubia. (2018) Therapeutic potential of pteridine derivatives: A comprehensive review. Medicinal Research Reviews 39:2, pages 461-516.
Crossref
Crossref
Ronik S. Bhangoo, Munveer S. Bhangoo, Aaron R. Mangold & William W. Wong. (2019) Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma. Advances in Radiation Oncology 4:1, pages 31-34.
Crossref
Crossref
Murali Kesavan & Graham P. Collins. (2018) Novel Targets and Therapies in T Cell Lymphoma. EMJ Oncology, pages 79-90.
Crossref
Crossref
Louise Photiou, Carrie van der Weyden, Christopher McCormack & H. Miles Prince. (2018) Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome. Current Oncology Reports 20:4.
Crossref
Crossref